Association of the STAT3 rs1053004 Polymorphism With Hepatocellular Carcinoma in Iraqi Patients With Hepatitis B
International Journal of Hepatology · 2026-01 · 2026 (1)
DOI: 10.1155/ijh/6122232 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Hepatology, online erschienen am 29.07.2026. Verfasst von Hawraa Ahmed Ali und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Techniques, Babylon Technical Institute, Al-Furat Al-Awsat Technical University, Al-Najaf, Iraq, atu.edu.iq. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
HCC is still one of the main causes of cancer‐related fatalities despite years of intensive attempts to prevent it. One known risk factor is a persistent hepatitis B virus (HBV) infection. Previous studies have indicated a contribution of the STAT3 signaling pathway to carcinogenesis through inflammation mechanisms. In this study, we tried to explore the correlation between STAT3 rs1053004 polymorphism and HCC occurrence in people with HBV infection in Iraq.
Methods
A case–control approach was applied with the inclusion of 80 patients with HCC due to HBV infection, 80 patients with CHB, and 80 healthy controls. The study was based on genotyping of the STAT3 rs1053004 polymorphism by a TaqMan SNP genotyping assay. Multivariate logistic regression analysis was used to assess the genetic association with disease risk, adjusting for potential confounding factors.
Results
The three groups under study had significantly different genotype and allele distributions ( p < 0.001). The HCC group had more T alleles than the other groups. Additionally, patients with the TT genotype had a greater risk of HCC (adjusted odds ratio [AOR] = 4.26; 95 % confidence interval [CI] = 1.89–9.62; p < 0.001), and this impact was observed in patients with cirrhosis, high serum HBV DNA levels, and negative HBeAg status.
Conclusion
STAT3 rs1053004 polymorphism plays a significant role in the development of HCC risk in people with HBV infection.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy Techniques, Babylon Technical Institute, Al-Furat Al-Awsat Technical University, Al-Najaf, Iraq, atu.edu.iq.
- Department of Medical Laboratory Techniques, Polytechnic College-Karbala, Al-Furat Al-Awsat Technical University, Al-Najaf, Iraq, atu.edu.iq.
- College of Dentistry, Mustansiriyah University, Baghdad, Iraq, uomustansiriyah.edu.iq.
ORCID-Profile: Hawraa Ahmed Ali, Thuraya Aamer Habeeb, Zahraa F Shaker, Zahraa Q Jasim
Zitieren
APA
Ali, H. A., Habeeb, T. A., Shaker, Z. F., & Jasim, Z. Q. (2026). Association of the STAT3 rs1053004 Polymorphism With Hepatocellular Carcinoma in Iraqi Patients With Hepatitis B. International Journal of Hepatology, 2026(1). https://doi.org/10.1155/ijh/6122232
Vancouver
Ali HA, Habeeb TA, Shaker ZF, Jasim ZQ. Association of the STAT3 rs1053004 Polymorphism With Hepatocellular Carcinoma in Iraqi Patients With Hepatitis B. International Journal of Hepatology. 2026;2026(1). doi:10.1155/ijh/6122232
BibTeX
@article{Ali2026,
author = {Ali, Hawraa Ahmed and Habeeb, Thuraya Aamer and Shaker, Zahraa F and Jasim, Zahraa Q},
title = {Association of the STAT3 rs1053004 Polymorphism With Hepatocellular Carcinoma in Iraqi Patients With Hepatitis B},
journal = {International Journal of Hepatology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ijh/6122232}
}
EUVIMED